Prostate Cancer - Results from #21360

Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer - Abstract January 27, 2014

ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer - Abstract January 27, 2014

18F-Choline PET/CT pitfalls in image interpretation: An update on 300 examined patients with prostate cancer - Abstract January 27, 2014

Radical prostatectomy for clinically localised prostate cancer at Rigshospitalet 1995-2011 - Abstract January 25, 2014

A cohort study investigating aspirin use and survival in men with prostate cancer - Abstract January 25, 2014

Efficacy of tegafur-uracil (UFT) administration in castration-resistant prostate cancer patients with a history of both alternative antiandrogen therapy and estramustine phosphate sodium hydrate therapy - Abstract January 25, 2014

31 P MR spectroscopic imaging combined with 1 H MR spectroscopic imaging in the human prostate using a double tuned endorectal coil at 7T - Abstract January 25, 2014

MRI target delineation may reduce long-term toxicity after prostate radiotherapy - Abstract January 25, 2014

Psychotherapy: A missing piece in the puzzle of post radical prostatectomy erectile dysfunction rehabilitation - Abstract January 25, 2014

The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer-A benchmark for high-tech external beam radiotherapy alone? - Abstract January 25, 2014

Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: Is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring? - Abstract January 25, 2014

Multicenter European external validation of a prostate health index-based nomogram for predicting prostate cancer at extended biopsy - Abstract January 25, 2014

Posterior urethral stenosis after treatment of prostate cancer - Abstract January 24, 2014

Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies - Abstract January 23, 2014

Melatonin may lower prostate cancer risk January 23, 2014

Analysis of prognostic factors in localized high-risk prostate cancer patients treated with HDR brachytherapy, hypofractionated 3D-CRT and neoadjuvant/adjuvant androgen deprivation therapy (trimodality therapy) - Abstract January 23, 2014

Genetic profiling to determine risk of relapse free survival in high-risk localized prostate cancer - Abstract January 23, 2014

The impact of baseline [-2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort - Abstract January 23, 2014

Fully automated prostate magnetic resonance imaging and transrectal ultrasound fusion via a probabilistic registration metric - Abstract January 23, 2014

Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancer - Abstract January 23, 2014

Page 1069 of 1435